Edap Tms (FOCL) Cash & Equivalents Growth (3y) (2012 - 2026)
Edap Tms (FOCL) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -5.28% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 12.24% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -0.44% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 3.08% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 254.96% |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -8.72% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 71.45% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -38.15% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 255.14% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -65.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.15% |
| Dec 31, 2025 | -31.78% |
| Sep 30, 2025 | -42.97% |
| Jun 30, 2025 | -26.65% |
| Mar 31, 2025 | -21.83% |
| Dec 31, 2024 | -16.10% |
| Sep 30, 2024 | -18.56% |
| Jun 30, 2024 | -15.31% |
| Mar 31, 2024 | 13.16% |
| Dec 31, 2023 | 16.68% |
| Sep 30, 2023 | 29.46% |
| Jun 30, 2023 | 46.99% |
| Mar 31, 2023 | 46.11% |
| Dec 31, 2022 | 40.72% |
| Sep 30, 2022 | 51.39% |
| Jun 30, 2022 | 37.92% |
| Mar 31, 2022 | 35.28% |
| Dec 31, 2021 | 34.43% |
| Sep 30, 2021 | 41.57% |
| Jun 30, 2021 | 38.42% |